|
2025 Conference Publication Topical sirolimus prevents cutaneous squamous cell carcinomas by disrupting the balance between differentiation and proliferationDousset, L., Zhou, C., Kao, Y., Tan, S., Muller, N., Sormani, L., Cox, C., Soyer, H.P., Stark, M.S., Wong, H., Roy, E. and Khosrotehrani, K. (2025). Topical sirolimus prevents cutaneous squamous cell carcinomas by disrupting the balance between differentiation and proliferation. Society for Investigative Dermatology (SID) 2025 Meeting, San Diego, CA United States, 7-10 May 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2025.06.777 |
|
2025 Conference Publication Spatial transcriptomics reveals molecular determinants of mortality in thin melanomaZhou, C., Tan, S.X., Kao, Y., Claeson, M., Brown, S., Lambie, D., Whiteman, D.C., Pandeya, N., Olsen, C.M., Barbour, A., MacGregor, S., Soyer, H.P., Stark, M.S., Hayward, N., Smithers, B.M., Nguyen, Q. and Khosrotehrani, K. (2025). Spatial transcriptomics reveals molecular determinants of mortality in thin melanoma. Society for Investigative Dermatology (SID) 2025 Meeting, San Diego, CA United States, 7-10 May 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2025.06.109 |
|
2025 Conference Publication Epithelial-mesenchymal transition and immune exclusion underpin the natural history of primary cutaneous melanomaTan, S.X., Muller, N., Zhou, C., Vipulaguna, N., Kao, Y., Whiteman, D.C., Soyer, H.P., Stark, M.S., Nguyen, Q. and Khosrotehrani, K. (2025). Epithelial-mesenchymal transition and immune exclusion underpin the natural history of primary cutaneous melanoma. Society for Investigative Dermatology (SID) 2025 Meeting, San Diego, CA United States, 7-10 May 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2025.06.953 |
|
2025 Conference Publication Dermatopathologist consensus is crucial for the development of artificial intelligence training data in dermatologyMuller, N., Tan, S., Rutjes, C., Katz, I., Khosrotehrani, K., Ge, Z. and Soyer, P. (2025). Dermatopathologist consensus is crucial for the development of artificial intelligence training data in dermatology. 21st EADO Congress & 11th World Congress of Melanoma, Athens, Greece, 3-5 April 2025. London, United Kingdom: Elsevier. doi: 10.1016/j.ejcskn.2025.100472 |
|
2024 Conference Publication Pathologist consensus for diagnostic labels is crucial in the developement of artificial intelligence training data in dermatologyMuller, N.M., Tan, S.X., Rutjes, C., Khosrotehrani, K., von Schuckmann, L., Betz-Stablein, B. and Soyer, H. P. (2024). Pathologist consensus for diagnostic labels is crucial in the developement of artificial intelligence training data in dermatology. 53rd Annual ESDR Meeting, Lisbon, Portugal, 4-7 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jid.2024.10.431 |
|
2024 Conference Publication Endothelial progenitors: Unlocking Tumor Vessel Normalization to Overcome Therapeutic Challenges in MelanomaSormani, L., Hashemi, G., Li, H., Zhou, C., Li, K., Chan, S., Tan, S.X., Nguyen, Q., Roy, E. and Khosrotehrani, K. (2024). Endothelial progenitors: Unlocking Tumor Vessel Normalization to Overcome Therapeutic Challenges in Melanoma. 53rd Annual ESDR Meeting, Lisbon, Portugal, 4-7 September 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.10.391 |
|
2024 Conference Publication 404 Spatial transcriptomic signatures in primary melanomas associated with sentinel node positivityMuller, N. M., Tan, S. X., Zhou, C., Kao, Y., Stark, M., Nguyen, Q. and Khosrotehrani, K. (2024). 404 Spatial transcriptomic signatures in primary melanomas associated with sentinel node positivity. 53rd Annual ESDR Meeting, 4-7 September 2024, Lisbon, Portugal. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.10.414 |
|
2024 Conference Publication Systems genetics multi-trait analysis of mouse wound healing reveals novel trait interactions with candidate genes characterised by their epidermal expression nicheMuller, N.M., Tan, S.X., Galbraith, J., Zhou, C., Roy, E. and Khosrotehrani, K. (2024). Systems genetics multi-trait analysis of mouse wound healing reveals novel trait interactions with candidate genes characterised by their epidermal expression niche. 53rd Annual ESDR Meeting, Lisbon, Portugal, 4-7 September 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.10.546 |
|
2024 Conference Publication Skin adverse events of anti-cancer treatments: An examination of drug-adverse events associationsKhosrotehrani, Kiarash, Salah, Samir, Pages, Cecile, Lacouture, Mario E. and Sibaud, Vincent (2024). Skin adverse events of anti-cancer treatments: An examination of drug-adverse events associations. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2023 Conference Publication Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nursesDielenseger, P., Lacouture, M., Khosrotehrani, K., De Barros Silva, G., Wolf, J. Ryan, Kerob, D., Trombetta, M., Atenguena, E.O., Pan, M., Scotte, F., Krakowski, I. and Dreno, B. (2023). Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.873 |
|
2023 Conference Publication Combined human endothelial colony-forming cells and mesenchymal stromal cells as a neuroprotectant in fetal growth-restricted newbornsChand, Kirat, Patel, Jatin, Matthews, Kate, Nano, Rachel, Musco, Hannah, Khosrotehrani, Kiarash, Colditz, Paul and Wixey, Julie (2023). Combined human endothelial colony-forming cells and mesenchymal stromal cells as a neuroprotectant in fetal growth-restricted newborns. IBRO 11th World Congress of Neuroscience, Granada, Spain, 9-13 September 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.ibneur.2023.08.249 |
|
2023 Conference Publication Dermocosmetics in management of cancer-related skin toxicities: International expert consensusDreno, Brigitte, Khosrotehrani, Kiarash, De Barros Silva, Giselle, Ryan-Wolf, Julie, Kerob, Delphine, Trombetta, Mark G., Atenguena Okobalemba, Etienne, Dielenseger, Pascale, Pan, Meng and Lacouture, Mario E. (2023). Dermocosmetics in management of cancer-related skin toxicities: International expert consensus. 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.e24115 |
|
2023 Conference Publication Dermocosmetics in management of cancer-related skin toxicities: International expert consensusDreno, Brigitte, Khosrotehrani, Kiarash, Silva, Giselle De Barros, Ryan-Wolf, Julie, Kerob, Delphine, Trombetta, Mark G., Okobalemba, Etienne Atenguena, Dielenseger, Pascale, Pan, Meng and Lacouture, Mario E. (2023). Dermocosmetics in management of cancer-related skin toxicities: International expert consensus. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2023 Conference Publication Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort studyLee, Ruby, Tseng, Anne, Liyanage, Upekha, Brown, Susan and Khosrotehrani, Kiarash (2023). Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort study. HOBOKEN: WILEY. |
|
2023 Conference Publication Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasisHashemi, G., Le Bourhis, L. Sormani, Dight, J., Zhou, C., Roy, E. and Khosrotehrani, K. (2023). Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10-13 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.jid.2023.03.1288 |
|
2023 Conference Publication Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipientsCox, Charlotte, Lee, Ruby, Liyanage, Upekha, Brown, Susan, Isbel, Nicole, Chambers, Daniel, Griffin, Anthony, Campbell, Scott, Hopkins, Peter, Schaider, Helmut, Soyer, Peter and Khosrotehrani, Kiarash (2023). Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients. HOBOKEN: WILEY. |
|
2023 Conference Publication Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapyWong, H., Lee, R., Chong, S., Kapadia, S., Murigneux, V., Freeman, M., Soyer, H., Roy, E. and Khosrotehrani, K. (2023). Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 12 - 13 May 2023. Oxford, United Kingdom: Elsevier. |
|
2023 Conference Publication 1511 Macrophages regulate endothelial progenitors’ quiescence and self-renewal during homeostasis and cutaneous wound healing via paracrine signalingSim, S., Kaur, S., Styke, C., Millard, S., Blumenthal, A., Pettit, A. and Khosrotehrani, K. (2023). 1511 Macrophages regulate endothelial progenitors’ quiescence and self-renewal during homeostasis and cutaneous wound healing via paracrine signaling. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1528 |
|
2023 Conference Publication A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancyMahon, Clare and Khosrotehrani, Kiarash (2023). A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancy. HOBOKEN: WILEY. |
|
2023 Conference Publication Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trialCox, C., Fry, K., Sivakumaran, Y., Spelman, L. and Khosrotehrani, K. (2023). Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial. 1st International Societies for Investigative Dermatology Meeting Abstract Supplement, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1530 |
